Vergoeding 2018-2022 voor ATC-subgroep A10BJ : Glucagonachtig peptide-1-agonisten (glp-1-agonisten)

  • Raming voor de totale Zvw-populatie
  2018 2019 2020 2021 2022
A10BJ01 Exenatide (Bydureon ®) 879.410 730.960 588.480 478.400 357.420
A10BJ02 Liraglutide (Victoza ®) 13.666.600 13.785.300 11.632.600 9.275.700 17.689.100
A10BJ03 Lixisenatide (Lyxumia ®) 90.202 83.417 65.761 42.772 35.806
A10BJ05 Dulaglutide (Trulicity ®) 2.757.000 2.640.200 3.586.600 4.413.300 7.303.000
A10BJ06 Semaglutide (Ozempic ®) 380.020 9.289.800 24.153.100 36.169.000 54.934.500
Totaal 17.773.232 26.529.677 40.026.541 50.379.172 80.319.826